Sarah Colombani, a BIM graduate, launches OcciCal Therapeutics

Sarah Colombani, research engineer at the PhyMedExp, is the lead researcher on the OcciCal Therapeutics project, a spin-off founded by five co-founders fromInserm, the CNRS and theUniversity of Montpellier. A winner of the Booster Innovation Montpellier (BIM) award since December, the company is developing a treatment designed to correct a common respiratory dysfunction in hospital settings.

Read the full article: Sarah Colombani, BIM award winner, launches OcciCal Therapeutics